Activity Preview


CIED Learning Pathway - Heart Rhythm 2017

Activity Type:

  • Course

This activity has expired

Release Date: 1/1/2018

Expiration Date: 12/31/2018

  • CME: 4.5
  • Participation - no CE credit: 4.5


The CIED Learning Pathway contains presentations from Heart Rhythm 2017, held on May 10 - 13 in Chicago, IL

Nonpharmacologic therapies for management of arrhythmias is expanding beyond merely pacemakers and defibrillators.  Advances in device technology now provide a host of features to assist with monitoring for disease, such as acute heart failure as well as occurrence of atrial arrhythmias even when asymptomatic.  These advances are especially impactful with remote monitoring, which provides prompt response to device-stored data. The future of implanted devices will likely be focused on monitoring physiologic parameters with the intent of early intervention to avert decompensation or adverse sequelae.

Earn up to 4.5 CME credits and 4.5 MOC points*

(*Each presentation is up to 0.5 CME credits/MOC points)

List Price






The CIED Learning Pathway contains the following presentations from Heart Rhythm 2017:

How Do You Choose Which Implantable Loop Recorder to Whom?
Faculty - Sze-Yuan Michael Ooi, MBBS

How to program ILRs for different clinical conditions - improving yield!
Faculty - Mevan N. Wijetunga, MD, FHRS

Patients with Reduced Left Ventricular Systolic Function
Faculty - Sana M. Al-Khatib, MD, MHS, FHRS, CCDS

Patients with Non-ischemic and Infiltrative Cardiomyopathies
Faculty - Suraj Kapa, MD, FHRS

ICD in Patients with Genetic Heart Diseases
Faculty - Wojciech Zareba, MD, PhD

Dual Chamber Pacing: Understanding Ventricular Pacing Avoidance Algorithms
Faculty - Abhishek J. Deshmukh, MD

Is LV Only Pacing as Good as BIV Pacing?
Faculty - Christophe Leclercq, MD, PhD

How to Optimize His Bundle Capture
Faculty - Gopi Dandamudi, MD, FHRS

Pulmonary Arterial Pressure Monitors - Post Market Data
Faculty - William T. Abraham, MD

Learning Objectives

Upon completion of this educational activity, participants will be able to:

1. To identify ICD indications for ischemic/nonischemic caridomyopathies and genetic heart disease
2. To understand how to optimize utilization of implantable loop recorders
3. To recognize varied techniques to enhance pacing therapy in patients with heart failure
4. Use of hemodynamic monitors in patients with conduction disease

Access Activity

Target Audience

Clinical Cardiac EPs
Directors of EP Labs
EP Fellows

CME Information

The Heart Rhythm Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Heart Rhythm Society designates this enduring material for a maximum of 4.5 AMA PRA Category 1 Credits™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The AMA has determined that physicians not licensed in the United States who participate in this CME activity are eligible for AMA PRA Category 1 Credit™.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 4.5 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.




It is the policy of the Heart Rhythm Society to ensure balance, independent objectivity, and scientific rigor in all its certified educational activities. Everyone involved in the planning and participation of continuing medical education activities is required to disclose any real or apparent conflicts of interest related to the content in his/her presentation(s) and also disclose discussions of unlabeled/unapproved uses of drugs or devices during his/her presentation(s).

Faculty - 
Sze-Yuan Michael Ooi, MBBS
Disclosure - Abbott Vascular, Biotronik

Mevan N. Wijetunga, MD, FHRS
Disclosure - Medtronic, Inc.

Sana M. Al-Khatib, MD, MHS, FHRS, CCDS
Disclosure – None

Suraj Kapa, MD, FHRS
Disclosure – St. Jude Medical, Boston Scientific Corp., Medtronic, Inc.

Wojciech Zareba, MD, PhD
Disclosure – Boston Scientific Corp., Gilead Sciences, Inc., Zoll Medical Corporation.

Abhishek J. Deshmukh, MD
Disclosure – None

Christophe Leclercq, MD, PhD
Disclosure – Medtronic, Inc., St. Jude Medical, Boston Scientific Corp., Biotronik, Sorin Group.

Gopi Dandamudi, MD, FHRS
Disclosure – Medtronic, Inc.

William T. Abraham, MD
Disclosure – Zoll Medical Corporation, Medtronic, Inc., Novartis Pharmaceuticals Corp., Sorin Group, Abbott Vascular, St. Jude Medical, CVRx Inc., Respicardia, Sunshine Heart.

Planners – 
Thomas Deering, MD, FHRS
HR2017 Program Chair
Disclosure - Pfizer, Inc., Medtronic, Inc., Zywie, CorMatrix, Boston Scientific Corp., Janssen Pharmaceuticals, Spectranetics Corporation, St. Jude Medical, Sorin Group.

Andrea Russo, MD, FHRS
HR2017 Abstract Chair
Disclosure – Medtronic, Inc., Boston Scientific Corp., St. Jude Medical, Biotronik. Boehringer Ingelheim

Staff – 
Russell Werlinich, CMP
Disclosures – None

Chloe Thomas
Disclosures - None


Allegations of conflict of interest and bias are taken seriously and are investigated by the Ethics Oversight Committee, Scientific Sessions Program Committee and/or the Education Committee. Your complaint will be referred to the appropriate committee, and you will be informed in writing of the outcome of its review and decision. Submit a confidential complaint by completing the form at or submit an email message to